| 1 |
29738245 | Enzyme-Responsive Charge-Reversal Polymer-Mediated Effective Gene Therapy for Intraperitoneal Tumors. | 2018 Jun 11 |
1 |
| 2 |
22922573 | The synergistic effects of low-dose irinotecan and TRAIL on TRAIL-resistant HT-29 colon carcinoma in vitro and in vivo. | 2012 Nov |
5 |
| 3 |
18714167 | Synergism of CPT-11 and Apo2L/TRAIL against two differentially sensitive human colon tumor xenografts. | 2008 |
2 |
| 4 |
17431115 | S-phase checkpoints regulate Apo2 ligand/TRAIL and CPT-11-induced apoptosis of prostate cancer cells. | 2007 Apr |
6 |
| 5 |
15604280 | Elimination of hepatic metastases of colon cancer cells via p53-independent cross-talk between irinotecan and Apo2 ligand/TRAIL. | 2004 Dec 15 |
9 |
| 6 |
12907654 | Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11. | 2003 Aug 1 |
4 |
| 7 |
14645705 | Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy. | 2003 Dec 9 |
4 |
| 8 |
12032863 | Enhanced tumor killing by Apo2L/TRAIL and CPT-11 co-treatment is associated with p21 cleavage and differential regulation of Apo2L/TRAIL ligand and its receptors. | 2002 May 16 |
13 |
| 9 |
12384541 | Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with chemotherapeutic agents on patients' colon tumors grown in SCID mice. | 2002 Oct 15 |
6 |
| 10 |
10626806 | Tumor necrosis factor-related apoptosis-inducing ligand's antitumor activity in vivo is enhanced by the chemotherapeutic agent CPT-11. | 1999 Dec 15 |
5 |